Literature DB >> 21511273

Cytokine gene expression in the tissues of dogs infected by Leishmania infantum.

M A G Barbosa1, G Alexandre-Pires, M Soares-Clemente, C Marques, O Roos Rodrigues, T Villa De Brito, I Pereira Da Fonseca, L C Alves, G M Santos-Gomes.   

Abstract

Canine leishmaniosis (CanL) caused by the protozoan parasite Leishmania infantum is a chronic systemic disease that is endemic in certain parts of the world. The domestic dog is the most important reservoir of L. infantum and is the main source of infection for other animals and for the human population. The aim of this study was to evaluate and compare the level of expression of genes encoding particular cytokines (interleukin [IL]-12, interferon [IFN]-γ, IL-2 and IL-4) in different tissues and organs of 53 adult dogs with or without clinical signs of leishmaniosis and after treatment for the disease. Asymptomatic dogs showed high expression of genes encoding IL-4 in blood leucocytes and of genes encoding IL-12 and IL-2 in lymph nodes. Blood leucocytes from symptomatic dogs had a mixed Th1 and Th2 cytokine gene expression profile, but lymph nodes from these animals had dominant IL-2 and IFN-γ gene expression, while bone marrow appeared to be unresponsive. The predominance of IL-4 gene expression in the blood of asymptomatic dogs may favour parasite replication, while the balance between Th1 and Th2 cytokine gene expression in the blood of symptomatic dogs may be important in reducing parasite replication and delaying the dissemination of Leishmania to other organs. The drugs used to treat CanL do not completely eliminate the parasite, so the high expression of the gene encoding IL-4 in blood leucocytes and the high expression of IL-12 and IL-4 mRNA in lymph nodes may reflect the persistence of residual Leishmania amastigotes. L. infantum appears able to regulate the host immune response in order to ensure its survival, but also to prevent the host from succumbing to infection. This guarantees its transmission and the completion of its life cycle.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511273     DOI: 10.1016/j.jcpa.2011.03.001

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  12 in total

1.  Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the Disease.

Authors:  Alhelí Rodríguez-Cortés; Eugenia Carrillo; Susanna Martorell; Felicitat Todolí; Ana Ojeda; Alba Martínez-Flórez; Alicia Urniza; Javier Moreno; Jordi Alberola
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

2.  Circulating Biomarkers of Immune Activation, Oxidative Stress and Inflammation Characterize Severe Canine Visceral Leishmaniasis.

Authors:  Manuela S Solcà; Bruno B Andrade; Melissa Moura Costa Abbehusen; Clarissa R Teixeira; Ricardo Khouri; Jesus G Valenzuela; Shaden Kamhawi; Patrícia Torres Bozza; Deborah Bittencourt Mothé Fraga; Valeria Matos Borges; Patrícia Sampaio Tavares Veras; Claudia Ida Brodskyn
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

3.  New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.

Authors:  Guilherme D Melo; Sophie Goyard; Hervé Lecoeur; Eline Rouault; Pascale Pescher; Laurence Fiette; Alexandre Boissonnas; Paola Minoprio; Thierry Lang
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

Review 4.  Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America.

Authors:  Claudia I Brodskyn; Shaden Kamhawi
Journal:  Front Cell Infect Microbiol       Date:  2018-07-26       Impact factor: 5.293

Review 5.  Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs.

Authors:  Carla Maia; Lenea Campino
Journal:  Front Cell Infect Microbiol       Date:  2018-09-06       Impact factor: 5.293

6.  Neutrophil properties in healthy and Leishmania infantum-naturally infected dogs.

Authors:  Amanda Brito Wardini; Lucia Helena Pinto-da-Silva; Natalia Rocha Nadaes; Michelle Tanny Nascimento; Bruno Mendes Roatt; Alexandre Barbosa Reis; Kelvinson Fernandes Viana; Rodolfo Cordeiro Giunchetti; Elvira Maria Saraiva
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

7.  Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment.

Authors:  Marcos Ferreira Santos; Graça Alexandre-Pires; Maria A Pereira; Cátia S Marques; Joana Gomes; Jorge Correia; Ana Duarte; Lídia Gomes; Armanda V Rodrigues; Alexandra Basso; Ana Reisinho; José Meireles; David Santos-Mateus; Maria Teresa Villa Brito; Luís Tavares; Gabriela M Santos-Gomes; Isabel Pereira da Fonseca
Journal:  Front Vet Sci       Date:  2019-10-18

8.  Expression of inducible nitric oxide synthase in macrophages inversely correlates with parasitism of lymphoid tissues in dogs with visceral leishmaniasis.

Authors:  Françoise P Sanches; Thaise Y Tomokane; Vânia L R Da Matta; Mary Marcondes; Carlos E P Corbett; Márcia D Laurenti
Journal:  Acta Vet Scand       Date:  2014-09-07       Impact factor: 1.695

9.  Insights on adaptive and innate immunity in canine leishmaniosis.

Authors:  Shazia Hosein; Damer P Blake; Laia Solano-Gallego
Journal:  Parasitology       Date:  2016-04-20       Impact factor: 3.234

10.  Parasite Specific Antibody Levels, Interferon-γ and TLR2 and TLR4 Transcripts in Blood from Dogs with Different Clinical Stages of Leishmaniosis.

Authors:  Sara Montserrat-Sangrà; Laura Ordeix; Pamela Martínez-Orellana; Laia Solano-Gallego
Journal:  Vet Sci       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.